iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

USFDA concludes inspection at Gland Pharma’s Hyderabad facility

4 Jan 2023 , 02:12 PM

Gland Pharma Limited informed that the USFDA has indicated the closure of inspection.

The company stated in an exchange filing that following the pre-market inspection for medical devices covering the USFDA’s Quality System/Current Good manufacturing practice regulations at its Dundigal Facility at Hyderabad from August 22, 2022 to August 25, 2022, it has received the Establishment Inspection Report (EIR) from the Office of Product Evaluation and Quality Center for Devices and Radiological Health, USFDA.

This report indicates closure of the inspection conducted the company’s facility.

Following this development, Gland Pharma was trading at Rs1,575.15 apiece, against its previous close of Rs1,575.75 on NSE. The counter touched an intraday high and low of Rs1,598.80 and Rs1,566 respectively.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Gland Pharma
  • Gland Pharma news
  • Gland Pharma USFDA
  • Pharma news
  • USFDA inspection
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.